Ellie Khadir DVM
Ellie Khadir is an expert in small- and large-animal disease models. At CBSET, she is actively involved in the evaluation of new medical therapies, directing preclinical studies evaluating the safety and efficacy of medical devices, cell-based therapies, and pharmaceuticals. Before joining CBSET, Ellie was a postdoctoral associate at the University of Minnesota’s Department of Neurology, where she led in vivo and in vitro research that supported clinical development of advanced gene therapies for rare genetic diseases. Previously, at the University’s Division of Infectious Disease, she conducted research in synthetic and molecular virology. Her scientific publications have appeared in a variety of peer-reviewed journals including PLos Neglected Tropical Diseases and Journal of Translational Medicine, among others. She holds a PhD in Anatomical Pathology and is a Doctor of Veterinary Medicine.
Company:CBSET
CBSET is a state-of-the-art translational research institute providing high-quality collaborative GLP studies from proof-of-concept through regulatory filings and IND-enabling studies. CBSET’s mission is to help medical device and biotechnology companies develop unique tools and new methods to promote early diagnosis of, and develop innovative treatments for complex diseases. CBSET provides full preclinical programs, plus specific study design supporting a range of applications in therapeutic and device development, as well as OLAW-assured, AAALAC-accredited animal research facilities. CBSET is based in Lexington (near Boston) and Grafton, MA (USA).
